Biotechnology

Growing with the Industry Since the '70s

Mintz attorneys have been working with biotech innovators and investors since the birth of the industry in the '70s. We help entrepreneurs get businesses off the ground. Help growing companies get funded. Help public corporations remain compliant with SEC requirements. And help investors and underwriters secure positions in industry leaders. Our professionals are embedded in the biotech ecosystem, and our clients rely on us for solutions to a broad range of complex issues.

Awards

U.S. News and Best Lawyers®

National Tier 1 ranking for Biotechnology Law and Health Care Law, "Best Law Firms"

M&A Today

Ranked as "Law firm of the Year (Biotechnology) – North America" in the Global Awards (2014 – 2017)

Managing Intellectual Property

US Life Sciences Patent Practice included on list of Top Patent Firms, and 9 attorneys named "Patent Stars" (2018)

IAM Patent 1000

Patent Practice and 6 life sciences attorneys recognized, "World's Leading Patent Practitioners" (2018)

Global 100

Ranked as "Law Firm of the Year (Biotechnology)" (2016 – 2017)

Chambers USA

Recognized for Litigation, Health Law, M&A, and Capital Markets

Our Experience

ITC Issues Exclusion Order To Protect Glycosyn’s Innovation

Mintz helped patent prosecution client Glycosyn defend its exclusive patent rights against the company's largest competitor, a global company selling infringing ingredients used in baby formula.

Representing Synlogic, Inc. from Inception to IPO

Mintz’s work for synthetic biotic company Synlogic Inc. has included raising over $100 million in three VC financing rounds. Mintz attorneys also helped Synlogic form a multiyear global R&D collaboration with AbbVie and raise more than $40 million in an IPO via a reverse merger with Mirna Therapeutics.

Biotech Companies Emerge Victorious in Multi-State Litigation

In federal and state cases alleging a large pharmaceutical client and its co-developer failed to adequately warn regarding the risk of personal injury, Mintz delivered wins on every substantive issue, in every case, in every jurisdiction.

Areas of Focus

Biosimilars

Our Approach

We take a collaborative approach to helping biotechnology companies advance their interests — bringing leading professionals from our transactions, IP, litigation, and regulatory practices together to provide comprehensive guidance and solutions.

Mintz helps researchers protect their innovations through the patent process. And we help protect products through the trademark and labeling regimes. We help companies and investors with their corporate and financing transactions and day-to-day corporate advisory work. And we help clinical trial teams develop programs and contracts that conform to FDA requirements. We also help increase clients' awareness of litigation risks before they launch products into the market — putting them in a better position when the inevitable litigation strikes their successful products.

FDA Regulation: Life Cycle Services